Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit

Perfusion

Volumn 17, Issue 2, 2002, Pages 117-123

  Amand, T ^a   Pincemail, J ^a   Blaffart, F ^a   Larbuisson, R ^a   Limet, R ^a   Defraigne, J O ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 8; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE; PANCREATIC ELASTASE; PEROXIDASE;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HEMATOCRIT; HEMOCONCENTRATION; HUMAN; INFLAMMATION; INTRAOPERATIVE PERIOD; LEUKOCYTE ACTIVATION; MALE; MEDIASTINUM; MORBIDITY; PARAMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; APHERESIS; BLOOD; COMPARATIVE STUDY; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; STANDARD;

AGED; BIOLOGICAL MARKERS; BLOOD COMPONENT REMOVAL; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PANCREATIC ELASTASE; PEROXIDASE;

EID: 0036203167     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659102pf544oa     Document Type: Article

References (31)

1. The balance of pro- and anti-inflammatory cytokines in cardiac surgery
2. Role of cytokines in the pathogenesis of cardiopulmonary bypass-induced multisystemic organ failure
3. Bio-materials in cardiopulmonary bypass
4. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery
5. Haemolysis during cardiopulmonary bypass: An in vivo comparison of standard roller pumps, nonocclusive roller pumps and centrifugal pumps
6. Mechanisms of the systemic inflammatory response
7. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass
8. Haematological effects of reinfused mediastinal blood after cardiac surgery
9. Apparent coagulopathy caused by infusion of shed blood and its prevention by washing of the infusate
10. Neutrophil activation during cardiopulmonary bypass in pediatric and adult patients
11. Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing artery bypass grafts or cholecystectomy
12. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans
13. Intra-operative autotransfusion in cardiac operations. Effect of intraoperative and postoperative transfusion requirements
14. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery
15. Safety and efficacy of autologous blood donation before elective aortic valve operation
16. Transfusional quality of residual blood from heart-lung machine after extracorporeal circulation
17. Efficacité respective du Cell Saver et de la récupération du circuit de CEC ultrafiltré en chirurgie cardiaque
18. Normothermic perfusion and lung function after cardiopulmonary bypass: Effects in pulmonary risk patients
19. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis
20. Aprotinin protect platelets against the initial effects of cardiopulmonary bypass
21. The quality of blood used for transfusion
22. Is the 'salvaged-cell syndrome' myth or reality?
23. Influence of different autotransfusion devices on the quality of salvaged blood
24. Continuous intravenous infusion of elastase in normal and agranulocytic minipigs - Effects on the lung and the blood coagulation system
25. Performance characteristics of a modified centrifuge bowl for blood salvage
26. The salvaged blood syndrome: A sequel to mechanochemical activation of platelets and leukocytes?
27. The role of different types of corticosteroids in the inflammatory mediators in cardiopulmonary bypass
28. Induction of IL-1 production in patients undergoing cardiopulmonary bypass
29. Cytokine release and neutrophil activation are not prevented by heparin-coated circuits and aprotinin administration
30. Qualitative assessment of blood washing with continuous autologous transfusion system (CATS)
31. Enzyme release and morphological changes induced by mechanical trauma blood cells